Pages that link to "Q59680238"

The following pages link to Guillaume Robert (Q59680238):

Displaying 44 items.

• Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness (Q21143866) (← links)
• Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death (Q28471941) (← links)
• Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. (Q34182185) (← links)
• The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells. (Q34227679) (← links)
• Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib. (Q35124193) (← links)
• A New Hydroxylated Nonaprenylhydroquinone from the Mediterranean Marine Sponge Sarcotragus spinosulus (Q35142065) (← links)
• Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. (Q35269865) (← links)
• The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML (Q36111614) (← links)
• The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death. (Q36119425) (← links)
• Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway (Q36926143) (← links)
• BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice (Q37197900) (← links)
• Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death (Q37295598) (← links)
• Targeting autophagy to fight hematopoietic malignancies. (Q37779468) (← links)
• Synthesis and anti-cancer activities of new sulfonamides 4-substituted-triazolyl nucleosides (Q38711249) (← links)
• In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid Malignancies (Q38720954) (← links)
• Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines (Q38981497) (← links)
• Ultrasound-assisted one-pot synthesis of anti-CML nucleosides featuring 1,2,3-triazole nucleobase under iron-copper catalysis. (Q39346588) (← links)
• Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. (Q39370827) (← links)
• Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy. (Q39528447) (← links)
• Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC. (Q39628692) (← links)
• Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest (Q40039631) (← links)
• SPARC represses E-cadherin and induces mesenchymal transition during melanoma development (Q40248571) (← links)
• HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. (Q40479151) (← links)
• BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia (Q41470921) (← links)
• Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation. (Q42092397) (← links)
• A new posttranslational regulation of REDD1/DDIT4 through cleavage by caspase 3 modifies its cellular function (Q42771842) (← links)
• Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation (Q43183491) (← links)
• Mechanism of action of the multikinase inhibitor Foretinib. (Q44633972) (← links)
• Sirtuin 7: a new marker of aggressiveness in prostate cancer (Q46309794) (← links)
• The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim. (Q48120159) (← links)
• Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudate. (Q48269638) (← links)
• An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia (Q48735981) (← links)
• IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential. (Q49303424) (← links)
• ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines. (Q51763031) (← links)
• Modular synthesis of new C-aryl-nucleosides and their anti-CML activity. (Q52588117) (← links)
• FeCl3-promoted and ultrasound-assisted synthesis of resveratrol O-derived glycoside analogs. (Q53838799) (← links)
• Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions. (Q54520926) (← links)
• The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression. (Q54641862) (← links)
• Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation (Q57063931) (← links)
• Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway (Q61350147) (← links)
• Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice (Q63681529) (← links)
• [Autophagy, a key player in leukemogenesis and a therapeutic target in hematopoietic malignancies] (Q87728141) (← links)
• LAMP2 expression dictates azacytidine response and prognosis in MDS/AML (Q90871227) (← links)
• Azacitidine resistance caused by LAMP2 deficiency: a therapeutic window for the use of autophagy inhibitors in MDS/AML patients? (Q91924128) (← links)